BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38024830)

  • 1. Tumor microenvironment in Hodgkin lymphoma: novel prognostic factors for assessing disease evolution.
    Turbatu A; Dobrea C; Stoian M; Barta CT; Halcu G; Birceanu A; Bordea AM; Ghimici CG; Oprea MM; Neacșu LD; Lupu AR; Coliță A
    J Med Life; 2023 Aug; 16(8):1201-1210. PubMed ID: 38024830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes.
    Nagpal P; Descalzi-Montoya DB; Lodhi N
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1311. PubMed ID: 33103852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.
    Barros MH; Vera-Lozada G; Soares FA; Niedobitek G; Hassan R
    Int J Cancer; 2012 Sep; 131(5):1142-52. PubMed ID: 22025264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Hodgkin lymphoma in a South Indian regional cancer center: its immunomorphology, tumor-associated macrophages, and association with Epstein-Barr virus.
    Zameer MA; Premalata CS; Arunakumari B; Appaji L; Rao CR
    Pediatr Hematol Oncol; 2015 May; 32(4):229-38. PubMed ID: 25252151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients.
    Antel K; Chetty D; Oosthuizen J; Mohamed Z; Van der Vyver L; Verburgh E
    Pathology; 2021 Aug; 53(5):628-634. PubMed ID: 33558066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
    Shen Z; Hu L; Yao M; He C; Liu Q; Wang F; Gu W; Wang Y; Dong M; Zhu T; Yin T; Li F; Jin Y; Huang S; Zhang H; Sang W;
    Int J Cancer; 2022 Jan; 150(2):327-334. PubMed ID: 34520566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for distinct mechanisms of immune suppression in EBV-positive and EBV-negative Hodgkin lymphoma.
    Adam M; Bekuretsion Y; Gebremedhin A; Kwiecinska A; Howe R; Petros B; Jerkeman M
    J Clin Exp Hematop; 2023; 63(4):230-239. PubMed ID: 38148013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of Epstein-Barr virus (EBV) infection in Hodgkin lymphoma patients.
    Myriam BD; Sonia Z; Hanene S; Teheni L; Mounir T
    J Infect Chemother; 2017 Mar; 23(3):121-130. PubMed ID: 28034523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphomagenesis in Hodgkin lymphoma.
    Matsuki E; Younes A
    Semin Cancer Biol; 2015 Oct; 34():14-21. PubMed ID: 25725205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment and RIG-I signaling molecules in Epstein Barr virus-positive and -negative classical Hodgkin lymphoma of the elderly.
    Satoh T; Wada R; Yajima N; Imaizumi T; Yagihashi S
    J Clin Exp Hematop; 2014; 54(1):75-84. PubMed ID: 24942949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
    Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
    Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
    Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
    Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of Tumor-Associated Macrophage Population Detected by CD68 PG-M1, CD68 KP1, and CD163 with Latent EBV Infection and Prognosis in Classical Hodgkin Lymphoma.
    Mavili HS; Isisag A; Tan A; Miskioglu M; Baraz LS; Nese N
    Turk Patoloji Derg; 2021; 37(2):130-138. PubMed ID: 33085074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein-Barr Virus in Classical Hodgkin Lymphoma.
    Santisteban-Espejo A; Perez-Requena J; Atienza-Cuevas L; Moran-Sanchez J; Fernandez-Valle MDC; Bernal-Florindo I; Romero-Garcia R; Garcia-Rojo M
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients.
    Laurent C; Fabiani B; Do C; Tchernonog E; Cartron G; Gravelle P; Amara N; Malot S; Palisoc MM; Copie-Bergman C; Glehen AT; Copin MC; Brousset P; Pittaluga S; Jaffe ES; Coppo P
    Haematologica; 2016 Aug; 101(8):976-84. PubMed ID: 27175027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1.
    Cader FZ; Vockerodt M; Bose S; Nagy E; Brundler MA; Kearns P; Murray PG
    Blood; 2013 Dec; 122(26):4237-45. PubMed ID: 24136166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed cell death-ligand 1 (PD-L1)
    Kimura S; Oshiro Y; Iwasaki H; Kadowaki M; Mihashi Y; Sakata T; Kawauchi S; Wang Z; Takamatsu Y; Takeshita M
    Clin Exp Med; 2022 Aug; 22(3):411-419. PubMed ID: 34515880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
    Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA
    Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells.
    Flavell JR; Baumforth KR; Wood VH; Davies GL; Wei W; Reynolds GM; Morgan S; Boyce A; Kelly GL; Young LS; Murray PG
    Blood; 2008 Jan; 111(1):292-301. PubMed ID: 17720884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells.
    Baumforth KR; Birgersdotter A; Reynolds GM; Wei W; Kapatai G; Flavell JR; Kalk E; Piper K; Lee S; Machado L; Hadley K; Sundblad A; Sjoberg J; Bjorkholm M; Porwit AA; Yap LF; Teo S; Grundy RG; Young LS; Ernberg I; Woodman CB; Murray PG
    Am J Pathol; 2008 Jul; 173(1):195-204. PubMed ID: 18502823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.